(Adds shares in paragraph 2, details throughout) Nov 20 (Reuters) – The US Food and Drug Administration declined to approve Capricor Therapeutics' experimental cell therapy for a fatal inherited
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Jonathan Stempel Nov 20 (Reuters) - Ford, Honda, Stellantis' FCA unit and Volkswagen sued…
Nov 20 (Reuters) - Databricks is in early talks to raise several billion dollars in…
By Jonathan Stempel NEW YORK, Nov 20 (Reuters) - A federal judge rejected on Friday…
Nov 20 (Reuters) - The US Food and Drug Administration declined to approve Capricor Therapeutics'…
By Ernest Scheyder Nov 20 (Reuters) - US Commerce Secretary Howard Lutnick asked battery startup Pure…
Nov 20 (Reuters) - Hackers this week breached a system that the US Department of…